
Charlie Dulberger
@chaaawie
Group Leader @BioNTech_Group. Biologics, Vaccine design, Structural biology, Mycobacteria. @Harvard with @fleshball @EricRubinLab, @UChiAdamsLab @UWBiochem
ID: 1005237536
https://scholar.google.com/citations?hl=en&user=AsIOxXsAAAAJ&sortby=pubdate&view_op=list_works&gmla= 12-12-2012 00:55:41
327 Tweet
418 Followers
740 Following

Excited to share the preclinical work underlying our #mRNA #monkeypox vaccine entering clinical trials. We hope to make an impact on this very scary disease and other emerging pox viruses via potential pan-pox protection elicited by our vaccine. BioNTech SE #mpox





Amazing commentary on recent intriguing paper from Digby Warner lab. Sarah Fortune on the relevance or not of viable Mtb found in aerosols of otherwise healthy people. But most of all, thank you for introducing me to the word "bummock" Sarah!



I am glad to share our most recent work Nature Communications: Genetically encoded transcriptional plasticity underlies stress adaptation in Mycobacterium tuberculosis (nature.com/articles/s4146…)



Woohoo, our paper on the discovery of 65 new phages dependent on conjugative plasmids is published in it's final form today in Nature Communications ! Here follows a thread (1/ ) link.springer.com/article/10.103…



Excited to share my dissertation work, out today in Nature Communications! Big question being asked: in developing targeted degraders for tuberculosis infection, how do we find suitable targets for this novel antibiotic modality? 🔗:nature.com/articles/s4146…



